Alopecia areata is an autoimmune condition that causes unpredictable hair loss on the scalp, face, and body. While the severity and progression can vary, the condition often has a significant psychological and emotional impact, affecting confidence, identity, and overall quality of life.
At Rejuvenation Dermatology, our Alopecia Areata Clinical Trials program is focused on advancing treatment options through regulated, ethically conducted research, while providing patients access to innovative therapies that may not yet be commercially available.
Integrated within our dermatology clinics across Canada, our clinical trials provide expert medical oversight, comprehensive scalp and hair assessments, and study-related care at no cost. By partnering with global pharmaceutical sponsors, our physicians contribute to the development of targeted therapies that address the underlying immune response driving hair loss.
Participation in alopecia areata clinical trials offers eligible patients structured care, close monitoring, and the opportunity to contribute to the future of dermatologic innovation.
STUDY INFO:
A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa
If you are interested in joining this study, please click here.
STUDY INFO:
CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry
If you are interested in joining this study, please click here.
STUDY INFO:
A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF RITLECITINIB IN PEDIATRIC PARTICIPANTS 6 TO LESS THAN 12 YEARS OF AGE WITH SEVERE ALOPECIA AREATA
If you are interested in joining this study, please click here.
STUDY INFO:
CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry
If you are interested in joining this study, please click here.
STUDY INFO:
CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry
If you are interested in joining this study, please click here.
EVIDENCE DRIVES ADVANCED HAIR LOSS SOLUTIONS
We believe effective treatment for alopecia areata must go beyond symptom management. Our clinical trials are designed to evaluate emerging therapies that target the immune pathways responsible for hair loss, generating data that drives meaningful advancements in care.
RESEARCH INTEGRATED INTO REAL CLINICAL PRACTICE
Clinical trials are conducted within our dermatology clinics, allowing patients to receive care in a trusted, physician-led environment. Our dermatologists understand the complex and often unpredictable nature of alopecia areata and provide personalized, medically guided support throughout the study.
ETHICS ARE NON-NEGOTIABLE
All alopecia areata trials undergo independent ethics board review before enrollment begins. Patients are fully informed, carefully screened, and monitored throughout the study with safety protocols that meet and exceed regulatory standards.
STANDARDIZED, NATIONAL EXECUTION
Our research network operates under centralized oversight and standardized protocols across all locations. This ensures consistency in care, efficient enrollment, and high-quality, reliable data.
Clinical research at Rejuvenation Dermatology is driven by a commitment to advance patient care through evidence-based medicine. Through participating in regulated clinical trials, the organization helps to shape development of safer, more effective dermatologic treatments while ensuring patients receive care that meets the highest ethical and scientific standards.
Participation in clinical research enables Rejuvenation physicians to remain at the forefront of dermatologic innovation and provides patients with access to therapies that may not yet be commercially available.
DERMATOLOGY-LED RESEARCH
All clinical trials are conducted under the supervision of board-certified dermatologists with experience in diagnosing and managing hair loss disorders. Patients receive expert care throughout every stage of participation.
NATIONAL REACH, LOCAL CARE
With multiple research sites across Canada, we combine the scale required for high-quality clinical research with the personalized care of local dermatology clinics, delivering consistency without sacrificing patient experience.
SAFETY FIRST, ALWAYS
Patient safety is our top priority. Strict eligibility criteria, continuous monitoring, and adherence to Good Clinical Practice (GCP) standards ensure a safe and controlled research environment.
RELIABLE DATA, TRUSTED BY SPONSORS
Our structured processes and experienced teams allow us to deliver consistent, high-quality data. This level of rigor ensures a seamless experience for both sponsors and participants.
RESEARCH WITH REAL IMPACT
Participation in alopecia areata clinical trials helps advance therapies that may redefine treatment standards. Patients play an active role in shaping the future of care for autoimmune hair loss.
Clinical trials may include patchy alopecia areata, alopecia totalis (complete scalp hair loss), or alopecia universalis (full body hair loss), depending on study criteria.
No. All study-related care, assessments, and investigational treatments are provided at no cost to eligible participants.
This depends on the study protocol. Some trials require discontinuation of current treatments, while others may allow certain therapies. Eligibility is determined during the screening process.
ALOPECIA AREATA CLINICAL TRIALS | CLINICAL TRIALS CANADA | REJUVENATION DERMATOLOGY
Rejuvenation Dermatology’s Clinical Trials Department is a national, multi-site research network dedicated to advancing dermatologic care through ethically conducted, regulated clinical research. Integrated within routine clinical practice, the department partners with global pharmaceutical sponsors to evaluate novel therapies and offers early access to innovative treatment options. The team supports industry-sponsored and investigator-initiated trials across a broad range of indications, collaborating closely with sponsors, CROs, investigators, and ethics boards to deliver high-quality data while maintaining a strong commitment to patient safety.
Since its inception, the division has evolved from a single research-focused clinic into a coordinated, multi-province research network. Today, it operates with standardized infrastructure, centralized oversight, and experienced investigators across Canada.
